U.S. Basic Materials Stock News

GitLab (GTLB) is back in focus after releasing GitLab 19.2, a product update centered on agentic automation, dependency scanning auto remediation, and security review tools, alongside a Forrester study highlighting GitLab Duo Agent Platform productivity outcomes. See our latest analysis for GitLab. GitLab's latest AI focused release and the Forrester study arrive as the stock trades at US$32.72, with a 30 day share price return of 23.61% and a 90 day share price return of 52.75%. The 1 year...

Earlier this week, TJX Companies drew attention as analysts projected higher upcoming earnings per share and revenue versus the prior year, alongside a Zacks Rank of #2, reflecting generally favorable sentiment toward the off‑price retailer. What stands out is that this optimism around TJX’s earnings outlook has held firm even while broader equity markets have been under pressure, hinting at perceived resilience in its value-focused retail model. We’ll now examine how this upbeat analyst...

Diodes (DIOD) has drawn investor attention after recent trading moves, with the stock down about 20% over the past month and roughly 8% over the past 3 months, despite positive annual revenue growth. See our latest analysis for Diodes. Over a longer stretch, Diodes shows strong upward momentum, with a year to date share price return of 69.20%, even though recent weakness includes a 7 day share price decline of 9.71% and a 1 year total shareholder return of 58.28%. If recent volatility has you...

Lumen Technologies previously announced that the New York Yankees selected it to power the network connecting Yankee Stadium and the team’s Tampa, Florida facilities, including a new 200-mph wind-rated data center linked by two diverse 100-gigabit fiber paths with automatic failover. This partnership gives Lumen a high-profile showcase for its Network-as-a-Service model, highlighting on-demand scalability for everything from fan Wi-Fi to media workloads across an AI-ready...

Artificial intelligence in healthcare is attracting fresh attention as investors weigh inflation trends, shifting interest rate expectations, and volatile energy costs across major economies. While higher yields and mixed growth signals are reshaping risk appetite, AI Healthcare Stocks sit at the intersection of cost pressure and the search for better outcomes, using data to support diagnostics, treatment decisions, and efficiency. The Transformative AI Healthcare Stocks screener focuses on...

US Foods Holding (USFD) stock offers investors a way to access the US foodservice distribution sector, with returns over the past month and the past 3 months providing a reference point for recent share performance. See our latest analysis for US Foods Holding. At a share price of $97.27, US Foods Holding has recently seen short term share price pressure, with its 1 day and 7 day share price returns both declining. However, its year to date share price return of 30.32% and 5 year total...

The planned rebuild of the Kirkuk to Mediterranean oil pipeline could reshuffle how crude moves out of the Middle East, and that matters for your portfolio. A more secure export route that reduces dependence on the Strait of Hormuz may ease oil price risk, and that can change the cost base for energy intensive sectors. This article looks at how that news links back to our Energy Intensive Industries screener and what it could mean for stock selection. You will see 3 stocks exposed to this...

Powell Industries has delivered an exceptionally strong long term share price return over the past five years, yet its current valuation checks lean expensive rather than cheap. Powell Industries has returned about 25x over the last five years, which puts extra focus on whether the current share price already reflects investors' expectations. Growing interest in power infrastructure for data centers can support elevated expectations for future earnings, but recent pressure on the share price...

Chemical has rewarded shareholders strongly over the past five years. At around US$187 a share, the stock now screens as expensive on earnings multiples and only mixed on broader valuation checks. This raises the question of how much of that strength is already reflected in the price. A 132.7% total return over five years points to a stock that has already delivered substantial gains for long term Chevron investors. Recent moves to expand oil production exposure in Iraq and support rising...

1st Source (SRCE) heads into its July 23 quarterly earnings report with investor attention centered on how the upcoming results align with recently more cautious analyst expectations for the bank’s earnings outlook. See our latest analysis for 1st Source. At a share price of $83.48, 1st Source has logged a 30 day share price return of 9.14% and a year to date share price return of 33.65%, while its 5 year total shareholder return of 123.60% points to stronger long run compounding. This...

In recent days, analyst commentary has highlighted growing optimism around Allegion’s upcoming July 23 earnings release, with forecasts calling for higher year-over-year revenue and earnings per share and an increased likelihood of an earnings beat versus prior estimates. This shift in expectations, set against an industry backdrop of firm demand for safety and security solutions despite cost pressures, points to rising confidence in Allegion’s ability to benefit from stronger electronic and...

Hewlett Packard Enterprise (HPE) is back in focus after expanding its partnership with ScanSource to distribute the HPE Juniper Networking portfolio, coinciding with fresh AI systems orders and higher earnings guidance. See our latest analysis for Hewlett Packard Enterprise. At a share price of $45.82, Hewlett Packard Enterprise has seen short term share price pressure, with a 7 day share price return down 5.60% and a 30 day share price return down 4.94%. This is set against strong momentum...

With softer U.S. inflation, shifting expectations for Federal Reserve rate moves, a weaker dollar and firmer oil prices, many investors are taking a fresh look at U.S. dividend stocks as potential sources of steady income and relative stability. This article focuses on large companies in traditionally resilient areas such as utilities, consumer staples, healthcare and industrials. All are drawn from a U.S. Dividend Stocks screener built around these macro shifts. You will see 3 stocks that...

Karooooo (KARO) reaffirmed its fiscal 2027 guidance after reporting Q1 2027 results, keeping the focus on subscription revenue, operating margins and earnings per share targets that management highlighted alongside record operating profit. See our latest analysis for Karooooo. Karooooo’s share price has risen 35.28% over the past month and 40.34% year to date, while the 3 year total shareholder return of 182.36% points to strong longer term momentum around the reaffirmed guidance and recent...

Construction Partners, Inc. previously announced it would release its fiscal 2026 third-quarter results on August 7, 2026, accompanied by an investor conference call that morning to discuss its performance. This update has drawn attention to the company’s improving free cash flow margins and acquisition-driven expansion, which are shaping how investors view its long-term fundamentals. Now we’ll examine how growing anticipation around the upcoming earnings release and improving free cash...

Barclays downgrade and 52 week low put LegalZoom.com (LZ) under the microscope LegalZoom.com (LZ) is back in focus after a Barclays downgrade and a slide to a fresh 52 week low, as investors reassess its growth outlook and its reaction to emerging AI tools. See our latest analysis for LegalZoom.com. The Barclays downgrade comes after a sharp rebound in LegalZoom.com’s recent share price performance, with a 30 day share price return of 38.6% and a 90 day gain of 18.95%. However, longer term...

Hinge Health stock has surged year to date, yet its valuation checks and pricing on traditional multiples suggest investors are now paying a premium rather than buying into a clear bargain. Year to date, Hinge Health has returned 91.2%, which puts recent enthusiasm for the stock front and center in any valuation discussion. The company’s ability to convert growth into durable cash flows can support current expectations, while any setback in scaling profitably may weigh heavily on what...

Tractor Supply (TSCO) is in focus after announcing a nationwide partnership with Instacart, giving customers access to same day delivery from more than 2,400 stores and broadening the retailer's rural reach. See our latest analysis for Tractor Supply. The Instacart partnership lands at a time when Tractor Supply’s share price has fallen 32% over 90 days and is down 40% year to date, with a 1 year total shareholder return declining 45%. This suggests sentiment has weakened even as investors...

Earlier this week, UiPath reported its first-ever quarterly GAAP operating profit, highlighted progress in moving its AI agentic products from pilot to production, and noted it still has about US$414 million available under its share repurchase program. A three-year agreement to build an AI-driven pricing platform for UK online retailer The Very Group shows how UiPath’s automation and AI capabilities are being applied to complex, margin-sensitive retail decisions. Next, we’ll examine how...

Monster Beverage (MNST) is back in the spotlight after announcing a 2-for-1 stock split, paired with strong international sales, sharpening attention on whether the current valuation matches underlying fundamentals. See our latest analysis for Monster Beverage. Despite a small 1 day share price decline of 2.44% to about $97.50, Monster Beverage has enjoyed strong momentum recently, with a 90 day share price return of 27.09% and a 1 year total shareholder return of 65.25%. This keeps attention...

Why Dan Buffery’s Appointment Matters for Houlihan Lokey Stock Houlihan Lokey (HLI) recently announced that Dan Buffery has joined its Capital Solutions Group as a Managing Director, taking a lead role in North American GP-led secondaries advisory within Equity Capital Solutions. For you as an investor, this kind of senior hire is less about headlines and more about what it might indicate for the firm’s advisory depth in private equity secondaries, infrastructure, and real assets. See our...

In recent days, Bernstein Liebhard LLP began investigating potential fiduciary duty breaches by certain Gartner directors and officers, while investors also looked back on Gartner’s identification of leading AI semiconductor vendors and its publication of the 2026 Magic Quadrant for Conversational AI Platforms. At the same time, the market’s focus has shifted to Gartner’s upcoming Q2 fiscal 2026 earnings report, with analysts’ expectations and its track record of outperforming EPS estimates...

Recent Performance Context for V.F Stock Without a specific news catalyst, V.F (VFC) is attracting attention as investors weigh its recent share performance against reported annual revenue of US$9.6b and net income of US$254.9m. The stock is up in the past month but down over the past 3 months, with a contrasting 1 year total return gain and a weaker multi year track record. This mixed picture is shaping how investors assess V.F today. See our latest analysis for V.F. V.F’s recent 1 day share...

Ionis Pharmaceuticals (NasdaqGS:IONS) has dosed the first participant in the Phase 1-2 ASCEND trial of ION337 for Dravet syndrome. The study marks the first clinical evaluation of ION337, a next generation RNA targeted therapy candidate. ION337 has FDA Fast Track designation for Dravet syndrome, a rare seizure disorder with no approved disease modifying treatments. For investors following Ionis Pharmaceuticals, this new trial adds a fresh data point to the company’s rare disease portfolio...